Refractory Ascites Definition and Management

Diagnostic Criteria

• The International Ascites Club defines refractory ascites as fluid overload which fails to respond to a restriction of salt intake and the maximum dose of diuretic treatment for at least one week, or reappears rapidly after therapeutic paracentesis 1, 2, 3
• Intensive diuretic therapy with spironolactone 400 mg/day and furosemide 160 mg/day for at least one week is required for diagnosis 2
• A salt-restricted diet of less than 5 g/day is recommended for patients with refractory ascites 1, 3
• Mean weight loss of less than 0.8 kg over four days indicates a lack of response to treatment 2, 3
• Urinary sodium output less than the sodium intake is a criterion for lack of response 1, 2
• Reappearance of grade 2-3 ascites within four weeks of initial mobilization indicates early ascites recurrence 1, 3

Diuretic-Induced Complications

• Hepatic encephalopathy, defined as the development of encephalopathy in the absence of any other precipitating factor, is a diuretic-induced complication 2, 3
• Renal impairment, defined as a >0.3 mg/dL increase of serum creatinine within 48 hours of baseline or 1.5-fold increase within 1 week, is a diuretic-induced complication 1
• Hyponatremia, defined as a decrease of serum sodium by >10 mEq/L to a serum sodium of <125 mEq/L, is a diuretic-induced complication 2, 3
• Electrolyte disorders, defined as a change in serum potassium to <3 mmol/L or >6 mmol/L despite appropriate measures, are diuretic-induced complications 1, 2
• Muscle cramps that prevent effective diuretic dosing are a diuretic-induced complication 2

Clinical Significance and Management

• Refractoriness of ascites is associated with a poor prognosis, with a median survival of about six months, according to the European Association for the Study of the Liver 2
• Patients with refractory ascites should be immediately referred to a liver transplant center for evaluation, as recommended by the American Association for the Study of Liver Diseases 2
• Once refractoriness is established, diuretics should generally be discontinued, as suggested by the European Association for the Study of the Liver 2
• Diuretics may be maintained only when renal sodium excretion on diuretics exceeds 30 mmol/day, according to the International Ascites Club 2, 4
• Large-volume paracentesis with albumin administration is the initial treatment of choice for refractory ascites, as recommended by the Clinical and Molecular Hepatology society 3

Management of Refractory Ascites in Patients Already on Spironolactone

Confirming Refractory Ascites

• The American Association for the Study of Liver Diseases recommends checking spot urine sodium-to-potassium ratio to verify true refractoriness, with a ratio >1 suggesting dietary non-compliance rather than true refractoriness 5
• The American Association for the Study of Liver Diseases suggests confirming maximum diuretic dosing, with spironolactone 400 mg/day plus furosemide 160 mg/day for at least one week, to establish refractoriness 5
• Patients with refractory ascites should be on a sodium-restricted diet, with less than 5 g/day (ideally 2 g or 90 mmol/day) sodium intake, as recommended by the American Association for the Study of Liver Diseases 5

Immediate Management Steps

• The American Association for the Study of Liver Diseases recommends discontinuing or reducing diuretics and initiating serial large-volume paracentesis (LVP) with albumin replacement, 6-8 g per liter removed, as first-line treatment for refractory ascites 5

Alternative Therapies for Recurrent Refractory Ascites

• The American Association for the Study of Liver Diseases suggests considering Transjugular Intrahepatic Portosystemic Shunt (TIPS) for patients with preserved liver function who repeatedly fail LVP, as it is superior to repeated LVP in reducing need for paracentesis and improving quality of life 5

Common Pitfalls to Avoid

• The American Association for the Study of Liver Diseases recommends avoiding the use of intravenous diuretics, as they cause acute reductions in renal perfusion and worsen kidney function 6
• The American Association for the Study of Liver Diseases suggests avoiding fluid restriction unless severe hyponatremia is present, with serum sodium <120-125 mEq/L, to prevent complications 5, 6

Monitoring During Transition

• The American Association for the Study of Liver Diseases recommends tracking weight and abdominal girth to determine paracentesis frequency needs, and monitoring serum creatinine, electrolytes, and sodium closely during diuretic withdrawal 5

Management of Refractory Ascites

Diagnosis and Treatment Approach

• The American Association for the Study of Liver Diseases recommends confirming refractory ascites by verifying adherence to a low-sodium diet and confirming maximum doses of diuretics, such as spironolactone 400 mg/day and furosémide 160 mg/day for at least one week, before considering alternative treatments 7, 8
• The European Association for the Study of the Liver suggests excluding medications that may exacerbate ascites, such as non-steroidal anti-inflammatory drugs, which can convert diuretic-sensitive ascites to refractory ascites 7
• The use of metolazone, a thiazide-like diuretic, may be considered in specific situations, with a documented combined effect of metolazone and furosémide producing significant diuresis in patients with refractory ascites 8

Risks and Complications

• The combination of metolazone and furosémide can cause severe volume depletion, acute reduction in renal perfusion, and worsening renal function, with a high risk of severe hyponatremia, hypokalemia, or hyperkalemia 8
• Aggressive diuresis can precipitate hepatic encephalopathy, and patients should be closely monitored for signs of encephalopathy 7, 8

Recommended Approach for Refractory Ascites

• The American Association for the Study of Liver Diseases recommends paracentesis with albumin administration as first-line treatment for refractory ascites, with immediate referral to a liver transplant center 7, 8
• Transjugular intrahepatic portosystemic shunt (TIPS) may be considered as an alternative for patients with preserved liver function who fail repeated paracenteses 8

Monitoring and Surveillance

• Close monitoring of serum electrolytes, including sodium, potassium, and creatinine, is essential when using metolazone, with daily measurements and adjustment of treatment as needed 8
• Daily weight measurements and monitoring for signs of encephalopathy are also crucial, with immediate cessation of treatment if severe hyponatremia, acute renal failure, or overt encephalopathy occurs 7, 8

Management of Refractory Ascites in Cirrhosis

Introduction to Alternative Diuretics

• The American Association for the Study of Liver Diseases recommends that torsémide or bumétanide may be indicated in cirrhotic patients with a suboptimal response to furosemide, but only after maximum doses of furosemide (160 mg/day) and spironolactone (400 mg/day) have been reached for at least one week 9

Context and Indication for Alternative Diuretics

• The European Association for the Study of the Liver suggests that torsémide and bumétanide are alternative loop diuretics that can improve natriuresis in patients with an inadequate response to furosemide 9

Comparison of Diuretic Efficacy

• The British Society of Gastroenterology notes that bumétanide is similar to furosemide in action and efficacy 10, 11